Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 42806-413

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 42806-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg-60ct (150mg 60ct)

Label for Bupropion Hydrochloride SR 150 mg extended-release tablets by Epic Pharma, LLC. The label states the dosage form as film-coated, extended-release tablets with a quantity of 60 tablets. It includes storage instructions, a warning against use with Wellbutrin products, pharmacist dispensing instructions, and manufacturer information for Yichang Humanwell Oral Solid Dosage Plant in China. The NDC is 42806-413.*

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical structure diagram showing the molecular structure of bupropion hydrochloride, the active ingredient in Bupropion Hydrochloride SR 150 mg extended-release tablets by Epic Pharma, LLC. The diagram includes distinct functional groups and chlorine substitution on a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.